for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Acer Therapeutics Inc Anticipates Submitting ACER-001 NDA In H1 2021

July 8 (Reuters) - Acer Inc:

* ACER THERAPEUTICS ANNOUNCES ADMINISTRATION OF ACER-001 IN A FASTED STATE INCREASED SYSTEMIC EXPOSURE OF PHENYLBUTYRATE IN HEALTHY VOLUNTEER FOOD EFFECT STUDY

* ACER THERAPEUTICS INC - ANTICIPATE SUBMITTING ACER-001 NDA IN H1 2021 Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up